Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Biogen signs Avonex distribution agreements

Aug. 23, 1996

Positive study results reported for CytoTherapeutics' encapsulated hCNTF device

Aug. 23, 1996

5-HT1D antagonists claimed by SmithKine Beecham

Aug. 23, 1996

Allelix describes dopamine D4 ligands for schizophrenia

Aug. 23, 1996

Zeneca files for U.K. marketing approval for Seroquel

Aug. 23, 1996

Allelix Biopharmaceuticals reports selective M1/M2 receptor ligands

Aug. 23, 1996

Draxis Health seeks Canadian approval of modafinil

Aug. 23, 1996

More tachykinin NK1 antagonists reported by Sandoz

Aug. 23, 1996

Calpain inhibitor PD-150606 shows neuroprotective effects

Aug. 16, 1996

SmithKline Beecham takes over Bradycor development

Aug. 16, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...